Cardiac Rhythm Management Devices Market Expected To Reach US$ 38.56 Bn By 2026

Cardiac Rhythm Management Devices Market Expected To Reach US$ 38.56 Bn By 2026

The latest market report published by Credence Research, Inc. “Cardiac Rhythm Management Devices Market Growth, Future Prospects, and Competitive Analysis, 2018 -2026” the cardiac rhythm management devices market was valued at US$ 20.88 Bn in 2017, and is expected to reach US$ 38.56 Bn by 2026, expanding at a CAGR of 6.96 % from 2018 to 2026.

Browse the full report Cardiac Rhythm Management Devices Market 2018 -2026 report at https://www.credenceresearch.com/report/cardiac-rhythm-management-devices-market

Market Insights

Cardiac rhythm management (CRM) devices market shows a lucrative growth with constant technological advancements driving the market. Advances such as extended battery life and making devices MRI-safe has created a positive environment for the growth of this market. Additionally, enabling wireless functioning of CRM devices and providing self-monitoring options has contributed to the lucrative growth of CRM devices market.

The major driver for the CRM market is the rising prevalence of arrhythmias across the globe. As per the Centers for Disease Control and Prevention (CDC) atrial fibrillation, the most common form of arrhythmia accounts for 2.7-6.1 million people in the U.S. as of 2015. The rise in adoption of unhealthy lifestyles has led to an increased risk of cardiovascular diseases, which in turn drives the growth of this market.

Download Free brochure of research report with TOC and Figures @  https://www.credenceresearch.com/sample-request/59025

Reporting of the adverse events such as bleeding or infections caused upon implantation of CRM devices, may restrain the market growth. Additionally, the risk of hacking of these devices from an unauthorized source could possesses a negative impact on the growth of CRM devices market. In September 2017, the FDA recalled around half million Abbott pacemakers from the market owing to its cyber security vulnerabilities. The implanted pacemakers were updated with a new software that enabled security.

The CRM devices market has worldwide outreach overcoming the unmet needs of arrhythmia across the globe. North America predominates this market owing to its vast disposable income, suitable reimbursement plans pertaining to CRM devices and presence of major manufacturers across this region. According to the report, National Audit of Cardiac Rhythm Management Devices by heathrhythmalliance.org, the pacemaker implant rate in the U.K. is on a gradual rise, ensuring positive growth of CRM devices market in Europe.

Market Competition Assessment:

The cardiac rhythm management devices market comprises a vast competitive pool, with players constantly striving for advanced technology. Medtronic Plc. dominates the CRM devices market. Its newest technology of leadless pacemaker: Micra is expected to change the market dynamics in the forecast period. Other players holding strong positions in this market are Abbott Laboratories, Inc., Biotronik, Inc., Boston Scientific Corporation, Integer Holdings Corporation, LivaNova, Plc., Philips Healthcare Informatics, Inc. & ZOLL Medical Corporation.

Key Market Movements:

  • Rise in adoption of unhealthy lifestyles has increased the risk for cardiovascular diseases thus leading to an increase in demand for CRM devices
  • Enhancement of existing technologies and the emergence of innovative devices drive the market providing remunerative growth
  • Stringent regulatory approval processes for CRM devices could restrain the growth of this market

Download Free brochure of research report with TOC and Figures @  https://www.credenceresearch.com/sample-request/59025

TOC:

Chapter 3. Global Cardiac Rhythm Management Devices Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Markey Dynamics
3.2.1. Drivers
3.2.2. Challenges
3.2.3. Opportunities
3.3. Attractive Investment Proposition, by Geography, 2017
3.4. Major Agreements, Partnerships and Collaborations
3.5. Competitive Landscape, by Key Players, 2017

Chapter 4. Global Cardiac Rhythm Management Devices Market, by Product Type, 2016-2026 (US$ Bn)
4.1. Overview
4.2. Pacemakers
4.2.1. Single chamber pacemakers
4.2.2. Dual chamber pacemakers
4.3. Defibrillators
4.3.1. Internal defibrillators
4.3.1.1. Transvenous implantable cardioverter defibrillator
4.3.1.2. Subcutaneous implantable cardioverter defibrillator
4.3.2. External defibrillators
4.4. Cardiac resynchronization therapy
4.4.1. Cardiac resynchronization therapy – pacemakers
4.4.2. Cardiac resynchronization therapy- defibrillators
4.5. Accessories
4.5.1. Pacing leads
4.5.2. Defibrillation leads

Chapter 5. Global Cardiac Rhythm Management Devices Market, by Geography, 2016-2026 (US$ Bn)
5.1. Overview
5.2. North America Cardiac Rhythm Management Devices Market Analysis, 2016-2026 (US$ Bn)
5.2.1. North America Cardiac Rhythm Management Devices Market, by Product Type, 2016-2026 (US$ Bn)
5.2.2. North America Cardiac Rhythm Management Devices Market, by Country, 2016-2026 (US$ Bn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe Cardiac Rhythm Management Devices Market Analysis, 2016-2026 (US$ Bn)
5.3.1. Europe Cardiac Rhythm Management Devices Market, by Product Type, 2016-2026 (US$ Bn)
5.3.2. Europe Cardiac Rhythm Management Devices Market, by Country, 2016-2026 (US$ Bn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. Rest of Europe
5.4. Asia Pacific Cardiac Rhythm Management Devices Market Analysis, 2016-2026 (US$ Bn)
5.4.1. Asia Pacific Cardiac Rhythm Management Devices Market, by Product Type, 2016-2026 (US$ Bn)
5.4.2. Asia Pacific Cardiac Rhythm Management Devices Market, by Country, 2016-2026 (US$ Bn)
5.4.2.1. Japan
5.4.2.2. China
5.4.2.3. Rest of APAC
5.5. Latin America Cardiac Rhythm Management Devices Market Analysis, 2016-2026 (US$ Bn)
5.5.1. Latin America Cardiac Rhythm Management Devices Market, by Product Type, 2016-2026 (US$ Bn)
5.5.2. Latin America Cardiac Rhythm Management Devices Market, by Country, 2016-2026 (US$ Bn)…

Chapter 6. Company Profiles
6.1. Abbott Laboratories Inc.
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Product Portfolio
6.1.4. Key Developments
6.2. Biotronik, Inc.
6.3. Boston Scientific Corporation
6.4. Integer Holdings Corporation
6.5. LivaNova, Plc.
6.6. Medtronic Plc. …

About Us:

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Contact:

Credence Research Inc

Name: Chris Smith (Global Sales Manager)

E-mail: sales@credenceresearch.com

Ph: 1-800-361-8290

Web:  https://www.credenceresearch.com

Facebook Comments

Share this post